You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Quetiapine for schizophrenia
|
|---|---|
| Published in |
Cochrane database of systematic reviews, April 2004
|
| DOI | 10.1002/14651858.cd000967.pub2 |
| Pubmed ID | |
| Authors |
Manit Srisurapanont, Benchalak Maneeton, Narong Maneeton, Sudheer Lankappa, Rahul Gandhi |
| Abstract |
Quetiapine is an atypical antipsychotic with, theoretically, a low propensity for movement disorder adverse effects. It is used for the treatment of schizophrenia and other psychoses. |
X Demographics
The data shown below were collected from the profiles of 9 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 2 | 22% |
| India | 1 | 11% |
| Unknown | 6 | 67% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 7 | 78% |
| Practitioners (doctors, other healthcare professionals) | 2 | 22% |
Mendeley readers
The data shown below were compiled from readership statistics for 190 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 190 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 25 | 13% |
| Researcher | 23 | 12% |
| Student > Ph. D. Student | 17 | 9% |
| Student > Doctoral Student | 15 | 8% |
| Student > Bachelor | 15 | 8% |
| Other | 37 | 19% |
| Unknown | 58 | 31% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 50 | 26% |
| Psychology | 24 | 13% |
| Pharmacology, Toxicology and Pharmaceutical Science | 15 | 8% |
| Nursing and Health Professions | 12 | 6% |
| Neuroscience | 4 | 2% |
| Other | 17 | 9% |
| Unknown | 68 | 36% |
Attention Score in Context
This research output has an Altmetric Attention Score of 10. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 September 2020.
All research outputs
#3,577,420
of 25,457,858 outputs
Outputs from Cochrane database of systematic reviews
#6,116
of 11,499 outputs
Outputs of similar age
#6,152
of 62,526 outputs
Outputs of similar age from Cochrane database of systematic reviews
#10
of 34 outputs
Altmetric has tracked 25,457,858 research outputs across all sources so far. Compared to these this one has done well and is in the 85th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,499 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 40.0. This one is in the 46th percentile – i.e., 46% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 62,526 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 90% of its contemporaries.
We're also able to compare this research output to 34 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 70% of its contemporaries.